BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37397988)

  • 1. Analyzing aberrant DNA methylation in Colorectal cancer uncovered intangible heterogeneity of gene effects in the survival time of patients.
    Khaniki SH; Shokoohi F; Esmaily H; Kerachian MA
    Res Sq; 2023 May; ():. PubMed ID: 37397988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing aberrant DNA methylation in colorectal cancer uncovered intangible heterogeneity of gene effects in the survival time of patients.
    Hajebi Khaniki S; Shokoohi F; Esmaily H; Kerachian MA
    Sci Rep; 2023 Dec; 13(1):22104. PubMed ID: 38092774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly methylated-differentially genes and pathways among Iranian patients with colorectal cancer.
    Ghorbani M; Azghandi M; Kerachian MA
    Cancer Cell Int; 2021 Jul; 21(1):346. PubMed ID: 34217303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of core differentially methylated genes in glioma.
    Xue J; Gao HX; Sang W; Cui WL; Liu M; Zhao Y; Wang MB; Wang Q; Zhang W
    Oncol Lett; 2019 Dec; 18(6):6033-6045. PubMed ID: 31788078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
    Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of DNA methylation for periodontitis.
    Zhao Z; Wang H; Li X; Hou J; Yang Y; Li H
    Int J Implant Dent; 2022 May; 8(1):22. PubMed ID: 35491409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC.
    Qian S; Sun S; Zhang L; Tian S; Xu K; Zhang G; Chen M
    Front Oncol; 2020; 10():556018. PubMed ID: 33134164
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
    Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
    Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.
    Huang CH; Han W; Wu YZ; Shen GL
    Front Genet; 2022; 13():817656. PubMed ID: 35991567
    [No Abstract]   [Full Text] [Related]  

  • 13. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
    Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
    Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
    BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of methylation profiling data of hyperplasia and primary and metastatic endometrial cancers.
    Wu X; Miao J; Jiang J; Liu F
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():161-166. PubMed ID: 28910750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-methylated gene markers for colorectal cancer in TCGA database.
    Zhang H; Sun X; Lu Y; Wu J; Feng J
    Exp Ther Med; 2020 Apr; 19(4):3042-3050. PubMed ID: 32256791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma.
    Wang JY; Lao J; Luo Y; Guo JJ; Cheng H; Zhang HY; Yao J; Ma XP; Wang B
    Int J Gen Med; 2021; 14():9419-9431. PubMed ID: 34908869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
    Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
    J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.